- •Abbreviations
- •1 Overview of Antimicrobial Therapy
- •Factors in Antibiotic Selection
- •Factors in Antibiotic Dosing
- •Microbiology and Susceptibility Testing
- •PK/PD and Other Considerations in Antimicrobial Therapy
- •Antibiotic Failure
- •Pitfalls in Antibiotic Prescribing
- •References and Suggested Readings
- •2 Empiric Therapy Based on Clinical Syndrome
- •Empiric Therapy of CNS Infections
- •Empiric Therapy of HEENT Infections
- •Empiric Therapy of Lower Respiratory Tract Infections
- •Empiric Therapy of GI Tract Infections
- •Empiric Therapy of Genitourinary Tract Infections
- •Empiric Therapy of Sexually Transmitted Diseases
- •Empiric Therapy of Bone and Joint Infections
- •Empiric Therapy of Skin and Soft Tissue Infections
- •Sepsis/Septic Shock
- •Febrile Neutropenia
- •Transplant Infections
- •Toxin-Mediated Infectious Diseases
- •Bioterrorist Agents
- •References and Suggested Readings
- •Gram Stain Characteristics of Isolates
- •Parasites, Fungi, Unusual Organisms in Blood
- •Parasites, Fungi, Unusual Organisms in CSF/Brain
- •Parasites, Fungi, Unusual Organisms in Lungs
- •Parasites, Fungi, Unusual Organisms in Heart
- •Parasites, Fungi, Unusual Organisms in the Liver
- •References and Suggested Readings
- •5 HIV Infection
- •HIV Infection Overview
- •Stages of HIV Infection
- •Acute (Primary) HIV Infection
- •Initial Assessment of HIV Infection
- •Indications for Treatment of HIV Infection
- •Antiretroviral Treatment
- •Treatment of Other Opportunistic Infections in HIV
- •HIV Coinfections (HBV/HCV)
- •References and Suggested Readings
- •6 Prophylaxis and Immunizations
- •Surgical Prophylaxis
- •Post-Exposure Prophylaxis
- •Chronic Medical Prophylaxis
- •Endocarditis Prophylaxis
- •Travel Prophylaxis
- •Tetanus Prophylaxis
- •Immunizations
- •References and Suggested Readings
- •Empiric Therapy of CNS Infections
- •Empiric Therapy of HEENT Infections
- •Empiric Therapy of Lower Respiratory Tract Infections
- •Empiric Therapy of Vascular Infections
- •Empiric Therapy of Gastrointestinal Infections
- •Empiric Therapy of Bone and Joint Infections
- •Empiric Therapy of Skin and Soft Tissue Infections
- •Common Pediatric Antimicrobial Drugs
- •References and Suggested Readings
- •8 Chest X-Ray Atlas
- •References and Suggested Readings
- •9 Infectious Disease Differential Diagnosis
- •11 Antimicrobial Drug Summaries
- •Appendix
- •Malaria in Adults (United States)
- •Malaria in Children (United States)
- •Index
|
Chapter 6. Prophylaxis and Immunizations |
371 |
|
Table 6.11. Endocarditis Prophylaxis for Below-the-Waist (Genitourinary, |
|
||
Gastrointestinal) Procedures Involving an Infected Field*† (cont’d) |
|
||
Prophylaxis |
Reaction to Penicillin |
Antibiotic Regimen |
|
|
|
|
|
IV prophylaxis |
None |
Ampicillin 2 gm (IV) 30 minutes pre-procedure |
|
|
|
plus |
|
|
|
Gentamicin 80 mg (IM) or (IV) over 1 hour 60 minutes |
|
|
|
pre-procedure |
|
|
|
|
|
|
Non-anaphylactoid, |
Vancomycin 1 gm (IV) over 1 hour 60 minutes |
|
|
anaphylactoid |
pre-procedure |
|
|
|
plus |
|
|
|
Gentamicin 80 mg (IM) or (IV) over 1 hour 60 minutes |
|
|
|
pre-procedure |
|
|
|
|
|
*Endocarditis prophylaxis is directed against E.. faecalis, the usual SBE pathogen below the waist..
†Seto TB.. The case for infectious endocarditis prophylaxis.. Arch Intern Med 167:327–330, 2007..
Harrison JL, Hoen B, Prendergast BD. . Antibiotic Prophylaxis for Infective Endocarditis. . Lancet 371: 1317–1319, 2008..
Table 6.12. Q Fever Endocarditis Prophylaxis
Prophylaxis |
Antibiotic Regimen |
|
|
PO prophylaxis (for significant |
Doxycycline 100 mg (PO) of q12 h × 12 months |
valvulopathy* in acute Q fever |
Plus |
|
Hydroxychloroquine 200 mg (PO) q8h × 12 months |
|
|
*Significant valvulopathy: history of rheumatic fever, aortic bicuspid valve, ≥2 valve stenosis/ regurgitation, MVP, remodeled/thickened valve..
TRAVEL PROPHYLAXIS
Travelers may acquire infectious diseases from ingestion of fecally-contaminated water/ food, exchange of infected body secretions, inhalation of aerosolized droplets, direct inoculation via insect bites, or from close contact with infected birds/animals.
Recommendations to prevent infection in travelers consist of general travel precautions (Table 6..12), and specific travel prophylaxis regimens (Table 6..13)..
Table 6.13. General Infectious Disease Travel Precautions
Exposure |
Risk |
Precautions |
Unsafe water |
Diarrhea/ |
(fecally- |
dysentery, viral |
contaminated) |
hepatitis (HAV) |
|
|
•Avoid ingestion of unbottled/unpotable water.. Be sure bottled water has an unbroken seal and has not been opened/refilled with tap water..
•Avoid ice cubes made from water of uncertain of origin/ handling, and drinking from unclean glasses..
•Drink only pasteurized bottled drinks.. Be sure bottles/cans are opened by you or in your presence..
372 |
|
A n t i b i o t i c E s s e n t i a l s |
||
Table 6.13. General Infectious Disease Travel Precautions (cont’d) |
||||
|
|
|
|
|
Exposure |
Risk |
|
Precautions |
|
|
|
|
|
|
|
|
|
• Avoid drinking unpasteurized/warm milk; beer, wine, and |
|
|
|
|
pure alcoholic beverages are safe.. |
|
|
|
|
• Eat only canned fruit or fresh fruit peeled by you or in your |
|
|
|
|
presence with clean utensils.. |
|
|
|
|
• Avoid eating soft cheeses.. |
|
|
|
|
• Avoid eating raw tomatoes/uncooked vegetables that |
|
|
|
|
may have been exposed to contaminated water.. |
|
|
|
|
• Avoid using hotel water for tooth brushing/rinsing unless |
|
|
|
|
certain of purity.. Many hotels use common lines for bath/ |
|
|
|
|
sink water that is unsuitable for drinking.. |
|
|
|
|
• Avoid wading/swimming/bathing in lakes or rivers.. |
|
Food-borne |
Diarrhea/ |
• Eat only seafood/poultry/meats that are freshly cooked |
||
(fecally- |
dysentery |
and served hot.. Avoid eating at roadside stands or small |
||
contaminated) |
|
local restaurants with questionable sanitary practices.. |
||
|
|
|
• “Boil it, peel it, or forget it..” |
|
Body fluid |
Viral hepatitis |
• Do not share utensils/glasses/straws or engage in “risky |
||
secretions |
(HBV, HCV, etc..), |
behaviors” involving body secretion exchange.. |
||
|
|
STDs, HIV/other |
• Avoid blood transfusion (use blood expanders instead).. |
|
|
|
retroviruses |
• Treat dental problems before travel.. |
|
|
|
|
|
|
Animal bite |
Animal bite- |
• Do not pet/play with stray dogs/cats.. Rabies and other |
||
|
|
associated |
infections are common in wild (and some urban) animals.. |
|
|
|
infections |
|
|
Flying insects |
Malaria, |
• Avoid flying/biting insects by wearing dark protective |
||
|
|
arthropod- |
clothing (long sleeves/pants) and using insect repellent on |
|
|
|
borne infections |
clothes/exposed skin, especially during evening hours.. |
|
|
|
• Minimize dawn-to-dusk outdoor exposure.. |
||
|
|
|
• Use screens/mosquito nets when possible.. |
|
|
|
|
• Do not use perfume, after shave, or scented deodorants/ |
|
|
|
|
toiletries that will attract flying insects.. |
|
Table 6.14. Travel Prophylaxis Regimens |
|
|||
|
|
|
|
|
|
|
Usual |
Prophylaxis |
|
Exposure |
Pathogens |
Regimens |
Comments |
|
|
|
|
|
|
|
|
E.. coli Salmonella |
Doxycycline 100 mg |
Observe without prophylaxis and |
|
|
Shigella |
(PO) q24h for duration |
treat mild diarrhea symptomatically |
|
|
Non-cholera |
of exposure |
with loperamide (2 mg).. Persons with |
|
|
vibrios |
or |
medical conditions adversely affected |
|
|
V.. cholerae |
Any quinolone (PO) for |
by dehydration caused by diarrhea |
|
|
Aeromonas |
duration of exposure |
may begin prophylaxis after arrival |
|
|
Plesiomonas |
or |
in country and continue for 1 day |
|
|
Rotavirus |
TMP–SMX 1 SS tablet |
after returning home.. Should severe |
|
|
Norwalk virus |
(PO) q24h for duration |
diarrhea/dysentery occur, continue/ |
|
|
Giardia lamblia |
of exposure |
switch to a quinolone, maximize oral |
|
|
Campylobacter |
|
hydration, and see a physician if possible.. |
|
|
|
|
|
|
Chapter 6. Prophylaxis and Immunizations |
373 |
||
Table 6.14. Travel Prophylaxis Regimens (cont’d) |
|
|
||
|
|
|
|
|
|
Usual |
Prophylaxis |
|
|
Exposure |
Pathogens |
Regimens |
Comments |
|
|
|
|
|
|
Traveler’s |
Yersinia |
|
Anti-spasmodics may be used for |
|
diarrhea |
Cryptosporidium |
|
symptomatic relief of mild, watery |
|
|
Cyclospora |
|
diarrhea but are contraindicated in |
|
|
Enteroviruses |
|
severe diarrhea/dysentery.. Bismuth |
|
|
Amebiasis |
|
subsalicylate is less effective than |
|
|
|
|
antibiotic prophylaxis.. Most cases are |
|
|
|
|
due to enterotoxigenic E.. coli.. TMP– |
|
|
|
|
SMX is active against some bacterial |
|
|
|
|
pathogens and Cyclospora, but not |
|
|
|
|
against E.. histolytica or enteroviral |
|
|
|
|
pathogens (e..g.., Rotavirus, Norwalk |
|
|
|
|
agent).. Doxycycline is active against |
|
|
|
|
most bacterial pathogens and E.. |
|
|
|
|
histolytica, but misses Campylobacter, |
|
|
|
|
Cryptosporidium, Cyclospora, Giardia, |
|
|
|
|
and enteroviral pathogens.. Rifaxamin |
|
|
|
|
only active against E..coli.. Antibiotics |
|
|
|
|
are inactive against viral/parasitic |
|
|
|
|
pathogens causing diarrhea.. |
|
|
|
|
|
|
Meningococcal |
N.. meningitidis |
Pre-travel prophylaxis |
Acquired via close face-to-face |
|
meningitis |
|
Meningococcal |
contact (airborne aerosol/droplet |
|
|
|
conjugate vaccine |
exposure).. Vaccine is highly |
|
|
|
0..5 mL (IM) ≥ 1 month |
protective against N.. meningitidis |
|
|
|
prior to travel to |
serotypes A, C, Y, and W-135, but |
|
|
|
endemic/epidemic |
misses serotype B.. For areas with |
|
|
|
areas |
serogroup B may use meningococcal |
|
|
|
Post-exposure |
group B vaccine.. Alternately, consider |
|
|
|
chemoprophylaxis.. |
|
|
|
|
prophylaxis |
|
|
|
|
|
|
|
|
|
See p.. 358 |
|
|
|
|
|
|
|
Hepatitis A |
Hepatitis A virus |
HAV vaccine 1 mL (IM) |
HAV vaccine is better than immune |
|
(HAV) |
|
prior to travel, then |
globulin for prophylaxis.. Take care |
|
|
|
follow with a one-time |
to avoid direct/indirect ingestion |
|
|
|
booster 3, 6 months |
of fecally contaminated water.. HAV |
|
|
|
later |
vaccine is recommended for travel to |
|
|
|
|
all developing countries.. Protective |
|
|
|
|
antibody titers develop after 2 weeks.. |
|
|
|
|
|
|
Typhoid fever |
S.. typhi |
ViCPS vaccine 0..5 mL |
For the oral vaccine, do not |
|
|
|
(IM).. Booster every |
co-administer with antibiotics.. |
|
|
|
2 years for repeat |
Contraindicated in compromised |
|
|
|
travelers |
hosts and children < 6 years old.. |
|
374 |
|
A n t i b i o t i c E s s e n t i a l s |
||
Table 6.14. Travel Prophylaxis Regimens (cont’d) |
|
|||
|
|
|
|
|
|
Usual |
|
Prophylaxis |
|
Exposure |
Pathogens |
|
Regimens |
Comments |
|
|
|
|
|
|
|
|
or |
Take oral capsules with cold water.. |
|
|
|
Oral Ty21a vaccine 1 |
Degree of protective immunity is |
|
|
|
capsule (PO) q48h ×4 |
limited with vaccine.. Some prefer |
|
|
|
doses.. Booster every |
chemoprophylaxis the same as for |
|
|
|
5 years for repeat |
Traveler’s diarrhea (p.. 373).. |
|
|
|
travelers |
|
|
|
|
|
|
Yellow fever |
Yellow fever |
|
Yellow fever vaccine |
Vaccine is often required for travel |
|
virus |
|
0..5 mL (SC).. Booster |
to or from Tropical South America or |
|
|
|
every 10 years for |
Tropical Central Africa.. Administer |
|
|
|
repeat travelers |
1 month apart from other live |
|
|
|
|
vaccines.. Contraindicated in |
|
|
|
|
children < 4 months old; caution in |
|
|
|
|
children < 1 year old.. Reactions may |
|
|
|
|
occur in persons with egg allergies.. |
|
|
|
|
Immunity is probably life long, but a |
|
|
|
|
booster every 10 years is needed for |
|
|
|
|
vaccination certification by some |
|
|
|
|
countries.. |
|
|
|
|
|
Japanese |
Japanese |
|
JE vaccine 1 mL (SC) |
Recommended for travelers |
encephalitis |
encephalitis |
|
on days 0, 7, and 14 or |
planning prolonged (> 3 week) visits |
(JE) |
virus |
|
30.. Booster schedule |
during the rainy season to rural, |
|
|
|
not established |
endemic areas of Asia (e..g.., Eastern |
|
|
|
|
Russia, Indian subcontinent, China, |
|
|
|
|
Southeast Asia, Thailand, Korea, |
|
|
|
|
Laos, Cambodia, Vietnam, Malaysia, |
|
|
|
|
Philippines).. Administer 3, 2 weeks |
|
|
|
|
before exposure.. Children < 3 years |
|
|
|
|
may be given 0..5 mL (SC) on same |
|
|
|
|
schedule as adults.. |
|
|
|
|
|
Rabies |
Rabies virus |
|
HDCV, PCEC, or RVA |
Avoid contact with wild dogs/ |
|
|
|
1 mL (IM) on days 0, |
animals during travel.. Dose of rabies |
|
|
|
7, and 21 or 28 prior |
vaccine for adults and children are |
|
|
|
to travel |
the same.. A booster dose prior to |
|
|
|
|
travel is recommended if antibody |
|
|
|
|
levels are measured and are low.. |
|
|
|
|
|
|
Chapter 6. Prophylaxis and Immunizations |
375 |
||
Table 6.14. Travel Prophylaxis Regimens (cont’d) |
|
|
||
|
|
|
|
|
|
Usual |
Prophylaxis |
|
|
Exposure |
Pathogens |
Regimens |
Comments |
|
|
|
|
|
|
|
|
or |
|
|
|
|
HDCV 0..1 mL (ID) on |
|
|
|
|
days 0, 7, and 21 or 28 |
|
|
|
|
prior to travel |
|
|
|
|
|
|
|
Tetanus |
C.. tetani |
Tdap 0..5 ml (IM) |
Tdap preferred to Td since Tdap also |
|
Diphtheria |
C.. diphtheriae |
|
boosts pertussis immunity.. |
|
Pertussis |
B.. pertussis |
|
|
|
|
|
|
|
|
Table 6.15. Malaria Prophylaxis |
|
|
|
|
|
|
|
|
|
|
Area of |
|
|
|
Drug |
Exposure |
Adult Dose |
Comments |
|
|
|
|
|
|
Atovaquone/ |
Prophylaxis in all |
Adult tablets contain |
Begin 1–2 days before travel to |
|
proguanil |
areas |
250 mg atovaquone |
malarious areas.. Take daily at the |
|
(Malarone) |
|
and 100 mg proguanil |
same time each day while in the |
|
|
|
hydrochloride.. 1 adult |
malarious area and for 7 days after |
|
|
|
tablet orally, daily |
leaving such areas.. Contraindicated |
|
|
|
|
in persons with severe renal |
|
|
|
|
impairment (creatinine clearance |
|
|
|
|
< 30 mL/min).. Atovaquone/ |
|
|
|
|
proguanil should be taken with food |
|
|
|
|
or a milk drink.. Not recommended |
|
|
|
|
prophylaxis for pregnant women, |
|
|
|
|
and women breastfeeding.. |
|
|
|
|
|
|
Chloroquine |
Prophylaxis only |
300 mg base (500 mg |
Begin 1–2 weeks before travel to |
|
phosphate |
in areas with |
salt) orally, once/week |
malarious areas.. Take weekly on the |
|
(Aralen and |
chloroquine- |
|
same day of the week while in the |
|
generic) |
sensitive malaria |
|
malarious area and for 4 weeks after |
|
|
|
|
leaving such areas.. |
|
|
|
|
|
|
Doxycycline |
Prophylaxis in all |
100 mg orally, (with |
Begin 1–2 days before travel to |
|
|
areas |
food) daily |
malarious areas.. Take daily at the same |
|
|
|
|
time each day while in the malarious |
|
|
|
|
area and for 4 weeks after leaving such |
|
|
|
|
areas.. Contraindicated in children < 8 |
|
|
|
|
years and in pregnancy.. |
|
|
|
|
|
|
376 |
A n t i b i o t i c E s s e n t i a l s |
||
Table 6.15. Malaria Prophylaxis (cont’d) |
|
||
|
|
|
|
|
Area of |
|
|
Drug |
Exposure |
Adult Dose |
Comments |
|
|
|
|
Hydroxy |
An alternative to |
310 mg base (400 mg |
Begin 1–2 weeks before travel to |
chloroquine |
chloroquine for |
salt) orally, once/week |
malarious areas.. Take weekly on the |
sulfate |
prophylaxis only |
|
same day of the week while in the |
(Plaquenil) |
in areas with |
|
malarious area and for 4 weeks after |
|
chloroquine- |
|
leaving such areas.. |
|
sensitive malaria |
|
|
|
|
|
|
Mefloquine |
Prophylaxis |
228 mg base (250 mg |
Begin at least 2 weeks before |
(Larium) |
in areas with |
salt) orally, once/week |
travel to malarious areas.. Take |
|
mefloquine- |
|
weekly on the same day of the |
|
sensitive malaria |
|
week while in the malarious area |
|
(mefloquine |
|
and for 4 weeks after leaving |
|
resistance in SE |
|
such areas.. Contraindicated in |
|
Asia) |
|
persons allergic to mefloquine or |
|
|
|
related compounds (e..g.., quinine, |
|
|
|
quinidine) and in persons with |
|
|
|
active depression, a recent history |
|
|
|
of depression, generalized anxiety |
|
|
|
disorder, psychosis, schizophrenia, |
|
|
|
other major psychiatric disorders, |
|
|
|
or seizures.. Use with caution |
|
|
|
in persons with psychiatric |
|
|
|
disturbances or a previous history |
|
|
|
of depression.. Not recommended |
|
|
|
for persons with cardiac |
|
|
|
conduction abnormalities.. |
|
|
|
|
Primaquine† |
Prophylaxis for |
30 mg base (52..6 mg |
Begin 1–2 days before travel to |
|
short-duration |
salt) orally, daily |
malarious areas.. Take daily at the |
|
travel to areas |
|
same time each day while in the |
|
with principally |
|
malarious area and for 7 days after |
|
P.. vivax |
|
leaving such areas.. |
|
|
|
Contraindicated in persons with |
|
|
|
G6PD deficiency, pregnancy and |
|
|
|
breastfeeding unless the infant being |
|
|
|
breastfed has a documented normal |
|
|
|
G6PD level.. |
|
|
|
|